drugset / Trial / NCT01153958
Colposeptine for the Treatment of Bacterial Vaginosis
Phase 4
Terminated
133 enrolled
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, randomized, controlled and multi-center trial to assess the use of colposeptine in female subjects with bacterial vaginosis. A total of 480 subjects were planned to be enrolled in various centers in China.
Timeline
- Start
- 2010-07
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colposeptine | Unknown | — | Other |
| Comparator | Metronidazole | Small molecule | 400 mg | Oral |